PT738141E - Formulações de éster de sacarose e n-docosanol - Google Patents
Formulações de éster de sacarose e n-docosanol Download PDFInfo
- Publication number
- PT738141E PT738141E PT94927991T PT94927991T PT738141E PT 738141 E PT738141 E PT 738141E PT 94927991 T PT94927991 T PT 94927991T PT 94927991 T PT94927991 T PT 94927991T PT 738141 E PT738141 E PT 738141E
- Authority
- PT
- Portugal
- Prior art keywords
- sucrose ester
- docosanol
- sucrose
- formulations
- docosanol formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16652393A | 1993-12-13 | 1993-12-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT738141E true PT738141E (pt) | 2008-02-11 |
Family
ID=22603672
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT04075956T PT1473031E (pt) | 1993-12-13 | 1994-09-02 | Formulações de álcool c20 a c28 de éster de sacarose |
| PT94927991T PT738141E (pt) | 1993-12-13 | 1994-09-02 | Formulações de éster de sacarose e n-docosanol |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT04075956T PT1473031E (pt) | 1993-12-13 | 1994-09-02 | Formulações de álcool c20 a c28 de éster de sacarose |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5534554A (pt) |
| EP (2) | EP1473031B1 (pt) |
| JP (2) | JP4149511B2 (pt) |
| KR (1) | KR100322507B1 (pt) |
| CN (2) | CN1103586C (pt) |
| AT (2) | ATE383848T1 (pt) |
| AU (1) | AU693476B2 (pt) |
| CA (1) | CA2156063C (pt) |
| DE (2) | DE69435067T2 (pt) |
| DK (2) | DK0738141T3 (pt) |
| ES (2) | ES2309441T3 (pt) |
| HK (1) | HK1056116A1 (pt) |
| PT (2) | PT1473031E (pt) |
| SG (1) | SG43833A1 (pt) |
| WO (1) | WO1995016434A1 (pt) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2710854B1 (fr) * | 1993-10-08 | 1995-12-01 | Oreal | Emulsion huile-dans-eau utilisable pour l'obtention d'une crème. |
| AU780340B2 (en) * | 1996-09-17 | 2005-03-17 | Avanir Pharmaceuticals | Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides |
| US6440980B1 (en) * | 1996-09-17 | 2002-08-27 | Avanir Pharmaceuticals | Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs |
| AU742929B2 (en) * | 1996-09-17 | 2002-01-17 | Avanir Pharmaceuticals | Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides |
| US5952392A (en) * | 1996-09-17 | 1999-09-14 | Avanir Pharmaceuticals | Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition |
| AU7735298A (en) * | 1996-12-17 | 1998-07-15 | Lidak Pharmaceuticals | Use of C18 to C26 aliphatic alcohols for the manufacture of medicament in the t reatment of hyperproliferative skin disorders |
| US5948822A (en) | 1996-12-17 | 1999-09-07 | Lidak Pharmaceuticals | Treatment of hyperproliferative skin disorders with C18 to C26 alphatic alcohols |
| DE19718777A1 (de) * | 1997-05-03 | 1998-11-05 | Beiersdorf Ag | Verwendung von Estern aus Fettsäuren und Di- und Oligosacchariden gegen die Adhäsion von Mikroorganismen |
| US6046244A (en) * | 1997-11-05 | 2000-04-04 | Nexmed Holdings, Inc. | Topical compositions for prostaglandin E1 delivery |
| US6414028B1 (en) | 1997-11-05 | 2002-07-02 | Nexmed Holdings, Inc. | Topical compositions containing prostaglandin E1 |
| US20050203187A1 (en) * | 1998-06-01 | 2005-09-15 | Verbiscar Anthony J. | Formulations useful for the treatment of varicella zoster virus infections and methods for the use thereof |
| ITMI981528A1 (it) * | 1998-07-03 | 2000-01-03 | Recordati Ind Chimica E Farma | Formulazioni topiche di aciclovir |
| ATE298345T1 (de) | 1999-09-03 | 2005-07-15 | Cabby Business Inc | Effizientes verfahren zur herstellung sehr reiner sterinen |
| ATE384518T1 (de) * | 2000-01-31 | 2008-02-15 | Haerting S A | Zusammensetzungen enthaltend phytosterol- und policosanolester von fettsäuren zur herabsetzung des cholesterol- und triglyceridspiegels |
| PT102410A (pt) * | 2000-02-03 | 2001-08-30 | Qualitas Lab | Extraccao da fraccao ceroide do residuo resinoso de fabricacao de aglomerado negro de cortica com fluido supercritico |
| US7399790B2 (en) * | 2001-02-28 | 2008-07-15 | Konowalchuk Thomas W | Virucidal compositions |
| BR0213323A (pt) * | 2001-10-16 | 2005-01-25 | Avanir Pharmaceuticals | Inibição viral por n-docosanol |
| US6559182B1 (en) * | 2001-11-07 | 2003-05-06 | Purcell Jojoba International, Llc | Method for treatment of enveloped viruses using jojoba oil esters |
| US7214394B2 (en) * | 2002-05-31 | 2007-05-08 | Archer-Daniels-Midland Company | Policosanol compositions, extraction from novel sources, and uses thereof |
| GB0313830D0 (en) * | 2003-06-16 | 2003-07-23 | Unichema Chemie Bv | Surfactant composition |
| US20050074443A1 (en) * | 2003-10-03 | 2005-04-07 | Treadwell Benjamin V. | Methods of attenuating autoimmune disease and compositions useful therefor |
| EP2132215B1 (en) | 2007-02-28 | 2015-09-23 | The Governors of the University of Alberta | Compounds for preventing or treating viral infections and methods of use thereof |
| US8715715B2 (en) | 2008-11-03 | 2014-05-06 | Nal Pharmaceuticals Ltd. | Dosage form for insertion into the mouth |
| US20100209484A1 (en) * | 2009-02-13 | 2010-08-19 | Hoo-Kyun Choi | Transdermal Triptan Delivery System |
| FR2949329B1 (fr) * | 2009-08-31 | 2011-10-21 | Oreal | Composition cosmetique comprenant un alcane lineaire volatil et un ester de sucrose |
| CN102049050B (zh) * | 2009-11-02 | 2014-06-18 | 重庆华邦制药有限公司 | 抗疱疹病毒感染的药物组合物 |
| GB201207781D0 (en) | 2012-05-03 | 2012-06-13 | Restoration Of Appearance And Function Trust | Extracellular matrix - synthetic skin scaffold |
| CN103877019B (zh) * | 2013-10-31 | 2016-01-06 | 湖北科益药业股份有限公司 | 一种二十二醇乳膏 |
| CN116546966A (zh) * | 2020-12-14 | 2023-08-04 | 宝洁公司 | 制造包含蔗糖酯和溶剂的化妆品组合物的方法 |
| WO2022132519A1 (en) * | 2020-12-14 | 2022-06-23 | The Procter & Gamble Company | Cosmetic compositions comprising sucrose esters and solvents |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1459233A (en) * | 1973-08-29 | 1976-12-22 | Inst Rech Chim Biolog | Medicament containing a higher alkanol |
| US4200655A (en) * | 1978-08-15 | 1980-04-29 | Sterling Drug Inc. | Benzyl alcohol virucidal process |
| FR2492829A1 (fr) * | 1980-10-24 | 1982-04-30 | Oreal | Agents de surface non-ioniques derives du glucose, procede pour les preparer et compositions les contenant |
| US4536519A (en) * | 1981-06-15 | 1985-08-20 | Kao Soap Co., Ltd. | Emulsifying agent and emulsified cosmetics |
| US4670471A (en) * | 1981-11-03 | 1987-06-02 | Clark Lealand L | Treatment for inflammatory skin disease |
| DE3348500C2 (de) * | 1982-05-28 | 1998-10-22 | Eisai Co Ltd | beta,gamma-Dihydropolyprenylalkoholderivat |
| EP0158108B1 (en) * | 1984-03-05 | 1992-10-14 | Tonfer Inc. | Detergent composition |
| US4684479A (en) * | 1985-08-14 | 1987-08-04 | Arrigo Joseph S D | Surfactant mixtures, stable gas-in-liquid emulsions, and methods for the production of such emulsions from said mixtures |
| JPH0816066B2 (ja) * | 1986-07-18 | 1996-02-21 | エーザイ株式会社 | 持続性薬効製剤 |
| JPS63179817A (ja) * | 1987-01-19 | 1988-07-23 | Kobayashi Kooc:Kk | 水性クレンジング料 |
| US4900555A (en) * | 1987-02-26 | 1990-02-13 | Alza Corporation | Skin permeation enhancer compositions using sucrose esters |
| US4940586A (en) * | 1987-02-26 | 1990-07-10 | Alza Corporation | Skin permeation enhancer compositions using sucrose esters |
| US4865848A (en) * | 1987-02-26 | 1989-09-12 | Alza Corporation | Skin permeation enhancer compositions using sucrose esters |
| US4874794A (en) * | 1989-04-28 | 1989-10-17 | Lidak Biopharmaceuticals | Inflammatory disease treatment |
| US5070107A (en) * | 1989-04-28 | 1991-12-03 | Lidak Pharmaceuticals | Systemic antiviral treatment |
| US4956171A (en) * | 1989-07-21 | 1990-09-11 | Paco Pharmaceutical Services, Inc. | Transdermal drug delivery using a dual permeation enhancer and method of performing the same |
| US5194451A (en) * | 1989-11-02 | 1993-03-16 | Katz David H | Systemic anti-inflammatory treatment |
| US5166219A (en) * | 1989-11-02 | 1992-11-24 | Lidak Pharmaceuticals | Systemic anti-inflammatory treatment |
| JPH03157349A (ja) * | 1989-11-14 | 1991-07-05 | Lion Corp | 乳化組成物 |
| US5214071A (en) * | 1991-04-23 | 1993-05-25 | Summit Technology, Inc. | Corneal treatment agents |
| US5098896A (en) * | 1991-04-23 | 1992-03-24 | Summit Technology, Inc. | Corneal treatment agents |
| GB9204388D0 (en) * | 1992-02-29 | 1992-04-15 | Tioxide Specialties Ltd | Water-in-oil emulsions |
-
1994
- 1994-09-02 SG SG1996001710A patent/SG43833A1/en unknown
- 1994-09-02 DE DE69435067T patent/DE69435067T2/de not_active Expired - Lifetime
- 1994-09-02 EP EP04075956A patent/EP1473031B1/en not_active Expired - Lifetime
- 1994-09-02 AT AT94927991T patent/ATE383848T1/de active
- 1994-09-02 DE DE69435106T patent/DE69435106D1/de not_active Expired - Lifetime
- 1994-09-02 AT AT04075956T patent/ATE399004T1/de active
- 1994-09-02 PT PT04075956T patent/PT1473031E/pt unknown
- 1994-09-02 DK DK94927991T patent/DK0738141T3/da active
- 1994-09-02 PT PT94927991T patent/PT738141E/pt unknown
- 1994-09-02 CN CN94194951A patent/CN1103586C/zh not_active Expired - Lifetime
- 1994-09-02 CA CA002156063A patent/CA2156063C/en not_active Expired - Lifetime
- 1994-09-02 WO PCT/US1994/009908 patent/WO1995016434A1/en active IP Right Grant
- 1994-09-02 AU AU77192/94A patent/AU693476B2/en not_active Expired
- 1994-09-02 JP JP51673895A patent/JP4149511B2/ja not_active Expired - Lifetime
- 1994-09-02 ES ES04075956T patent/ES2309441T3/es not_active Expired - Lifetime
- 1994-09-02 DK DK04075956T patent/DK1473031T3/da active
- 1994-09-02 US US08/299,944 patent/US5534554A/en not_active Expired - Lifetime
- 1994-09-02 EP EP94927991A patent/EP0738141B1/en not_active Expired - Lifetime
- 1994-09-02 ES ES94927991T patent/ES2299173T3/es not_active Expired - Lifetime
-
1996
- 1996-06-12 KR KR1019960703083A patent/KR100322507B1/ko not_active IP Right Cessation
-
2002
- 2002-06-17 CN CNB021233632A patent/CN1223342C/zh not_active Expired - Lifetime
-
2003
- 2003-11-17 HK HK03108374A patent/HK1056116A1/xx not_active IP Right Cessation
-
2006
- 2006-05-02 JP JP2006128264A patent/JP2006206610A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN1142764A (zh) | 1997-02-12 |
| DE69435106D1 (de) | 2008-08-07 |
| DE69435067T2 (de) | 2008-05-15 |
| EP0738141A1 (en) | 1996-10-23 |
| ATE383848T1 (de) | 2008-02-15 |
| CA2156063A1 (en) | 1995-06-22 |
| CN1223342C (zh) | 2005-10-19 |
| JP2006206610A (ja) | 2006-08-10 |
| EP0738141A4 (en) | 1998-01-07 |
| ES2299173T3 (es) | 2008-05-16 |
| EP1473031B1 (en) | 2008-06-25 |
| HK1056116A1 (en) | 2004-02-06 |
| DK0738141T3 (da) | 2008-05-19 |
| JP4149511B2 (ja) | 2008-09-10 |
| CN1419911A (zh) | 2003-05-28 |
| US5534554A (en) | 1996-07-09 |
| DK1473031T3 (da) | 2008-10-20 |
| ES2309441T3 (es) | 2008-12-16 |
| KR100322507B1 (ko) | 2002-08-14 |
| DE69435067D1 (de) | 2008-03-06 |
| EP0738141B1 (en) | 2008-01-16 |
| JPH09506612A (ja) | 1997-06-30 |
| SG43833A1 (en) | 1997-11-14 |
| AU693476B2 (en) | 1998-07-02 |
| WO1995016434A1 (en) | 1995-06-22 |
| ATE399004T1 (de) | 2008-07-15 |
| CN1103586C (zh) | 2003-03-26 |
| AU7719294A (en) | 1995-07-03 |
| EP1473031A1 (en) | 2004-11-03 |
| CA2156063C (en) | 1999-06-29 |
| PT1473031E (pt) | 2008-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT738141E (pt) | Formulações de éster de sacarose e n-docosanol | |
| HK155195A (en) | Low-irritant detergent composition | |
| FI943377A (fi) | Vetyperoksidin valmistus | |
| GB9005523D0 (en) | Cosmetic composition | |
| FR2570778B1 (fr) | Accouplement d'arbres a forte elasticite | |
| DE3581663D1 (de) | Klare und stabile benzoylperoxidkompositionen. | |
| ES542447A0 (es) | "un procedimiento para preparar un derivado de cefem". | |
| IT1186748B (it) | Procedimento per la formazione di composizioni omogenee di carburanti contenenti una frazione di petrolio ed almeno un alcol alifatico a catena corta e composizioni omogenee cosi' ottenute | |
| GB8809027D0 (en) | Carbonylation of allylic alcohols | |
| ZA894667B (en) | Process for the preparation of 2,6-dichlorodiphenyl-amino-acetic derivatives | |
| IT1236222B (it) | Metodo per compensare la flessione di una lama patinatrice e lama patinatrice a flessione compensata | |
| DK0407815T3 (da) | Præparat indeholdende polyprenylforbindelser til bløde kapsler | |
| ITMI930801A0 (it) | Procedimento per l'esercizio di un calorimetro | |
| IT1182715B (it) | Procedimento per la produzione di un detergente e detergente cosi' ottenuto | |
| FI885708A0 (fi) | Foerfarande foer metylering av xantiner. | |
| ZA879447B (en) | Abscission of parts of plants | |
| DE3879792D1 (de) | Gerichtete-biosynthese eines milbemycinanaloges. | |
| NZ222421A (en) | Pharmaceutical compositions comprising 1,3-dioxane derivatives and a thromboxane a 2 synthesis inhibitor | |
| ES2024632B3 (es) | Caseta de separacion. | |
| DE3470306D1 (de) | N'-acylhydrazino-thiocarbonic-acid-o-carbamoylmethyl ester | |
| FR2584561B2 (fr) | Outil agricole tel qu'une ecrouteuse | |
| BR9103215A (pt) | Uniao de longarinas a colunas | |
| IT1215441B (it) | Composizioni farmaceutiche adattivita' spasmolitica contenente come principio attio idanpramina | |
| IT8520750V0 (it) | Struttura di pupazzo particolarmente per bambini | |
| IT8583319A0 (it) | Perfezionamenti alle cesoie per barre e cesoie per barre cosi'perfezionate. |